Bio Green Med Solution, Inc. (BGMS)
NASDAQ: BGMS · Real-Time Price · USD
0.960
-0.012 (-1.18%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Bio Green Med Solution Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 5 | 7 | 2 | 3 | 8 | 39 | |
| Market Cap Growth | -89.32% | 206.79% | -13.14% | -67.46% | -78.44% | 2.12% | |
| Enterprise Value | 2 | 3 | -1 | -3 | -15 | -1 | |
| Last Close Price | 0.96 | 1.48 | 90.24 | 640.80 | 2401.20 | 14003.98 | |
| PS Ratio | 7.09 | 9.71 | 54.98 | 6.48 | - | - | |
| PB Ratio | 0.76 | 1.06 | -1.09 | 4.48 | 0.53 | 1.03 | |
| P/TBV Ratio | 1.01 | 1.38 | - | 4.48 | 0.53 | 1.03 | |
| EV/Sales Ratio | 2.40 | 4.58 | - | - | - | - | |
| Debt / Equity Ratio | 0 | 0 | - | 0.06 | 0.01 | 0.00 | |
| Net Debt / Equity Ratio | -0.51 | -0.51 | 1.44 | -5.50 | -1.14 | -0.97 | |
| Net Debt / EBITDA Ratio | 0.42 | 0.42 | 0.26 | 0.13 | 0.66 | 1.64 | |
| Net Debt / FCF Ratio | 0.73 | 0.73 | 0.39 | 0.21 | 0.88 | 1.97 | |
| Asset Turnover | 0.12 | 0.12 | 0.01 | 0.02 | - | - | |
| Quick Ratio | 3.58 | 3.58 | 0.50 | 0.77 | 3.06 | 7.44 | |
| Current Ratio | 4.70 | 4.70 | 0.59 | 0.91 | 3.25 | 7.56 | |
| Return on Equity (ROE) | -128.45% | -128.45% | - | -272.63% | -79.05% | -52.03% | |
| Return on Assets (ROA) | -85.79% | -85.79% | -116.33% | -86.33% | -48.56% | -35.01% | |
| Return on Capital Employed (ROCE) | -123.00% | -123.00% | 552.20% | -3952.30% | -134.70% | -59.40% | |
| Earnings Yield | -265.95% | -41.34% | -474.30% | -828.78% | -253.46% | -47.58% | |
| FCF Yield | -90.02% | -65.77% | -338.00% | -592.25% | -249.11% | -47.86% | |
| Buyback Yield / Dilution | -9692.40% | -9692.40% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.